Article

Identification of Tumor Antigens and Immune Subtypes of Acute Myeloid Leukemia for mRNA Vaccine Development

2022-10-26

Abstract excerpt

<h4>Background</h4> Acute myeloid leukemia (AML) is a highly aggressive hematological malignancy, and there has not been any significant improvement in therapy of AML over the past several decades. The mRNA vaccines have become a promising strategy against multiple cancers, however, its application on AML remains undefined. In this study, we aimed to identify novel antigens for developing mRNA vaccines against AM...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: efa3905a-57d2-5472-a162-dc9d3e16736f
DOI: 10.1101/2022.10.25.513524

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Tumor Antigens and Immune Subtypes of Acute Myeloid Leukemia for mRNA Vaccine DevelopmentDOI 10.1101/2022.10.25.513524Read

Identification of immunity- and ferroptosis-related signature genes as potential design targets for mRNA vaccines in AML patients.Semantic proximity Read

Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia PatientsSemantic proximity Read

A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia.Semantic proximity Read

Single-cell data revealed the function of natural killer cells and macrophage cells in chemotherapy tolerance in acute myeloid leukemiaSemantic proximity Read

Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy developmentSemantic proximity Read

Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysisSemantic proximity Read

The cellular state space of AML unveils novel <i>NPM1</i> subtypes with distinct clinical outcomes and immune evasion propertiesSemantic proximity Read

Dynamics of Leukemic Blast and Immune Cell Populations in Acute Myeloid LeukemiaSemantic proximity Read

Molecular Characterization of the Highest Risk Adult Patients with Acute Myeloid Leukemia (AML) through Multi-omics ClusteringSemantic proximity Read

Identification of Molecular and Immune Prognostic Classifiers of Acute Myeloid LeukemiaSemantic proximity Read

The potential novel immune-related prognostic factors for acute myeloid leukemiaSemantic proximity Read

Integrative Genomic and Immune Profiling to Identify and Characterize High-Risk Subgroups in Acute Myeloid Leukemia: Development of a 20-Gene Predictive Signature and Its Clinical Implications.Semantic proximity Read